9.4 C
New York
Thursday, December 18, 2025

BMO reaffirms Outperform rating for Eli Lilly stock following positive weight loss data


Eli Lilly stock rating reiterated at Outperform by BMO on weight loss data

Related Articles

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe

Latest Articles